The global market for Rasagiline Tablet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson"s disease or as an adjunct therapy in more advanced cases.

The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identified it as a potential drug for Parkinson"s disease, and working with collaborators at Technion – Israel Institute of Technology in Israel and the drug company, Teva Pharmaceutical, identified the R-isomer as the active form of the drug. Teva brought it to market in partnership with Lundbeck in Europe and Eisai in the US and elsewhere. It was approved in Europe in 2005 and in the US in 2006.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rasagiline Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rasagiline Tablet.

The Rasagiline Tablet market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rasagiline Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rasagiline Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rasagiline Tablet Market Report

Report Metric	Details
Report Name	Rasagiline Tablet Market
Segment by Type	0.5 mg/Pcs 1 mg/Pcs
Segment by Application	Under 40 Years Old 40-65 Years Old Above 65 Years Old
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva Pharmaceutical, Lundbeck, Sun Pharmaceutical, Apotex, Taj Pharma, Mylan, Takeda Pharmaceutical, Sandoz, Intas Pharmaceuticals, Natco Pharma, Ajanta Pharma, Orchid Pharma, Alkem Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rasagiline Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rasagiline Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rasagiline Tablet Market report?

Ans: The main players in the Rasagiline Tablet Market are Teva Pharmaceutical, Lundbeck, Sun Pharmaceutical, Apotex, Taj Pharma, Mylan, Takeda Pharmaceutical, Sandoz, Intas Pharmaceuticals, Natco Pharma, Ajanta Pharma, Orchid Pharma, Alkem Laboratories

What are the Application segmentation covered in the Rasagiline Tablet Market report?

Ans: The Applications covered in the Rasagiline Tablet Market report are Under 40 Years Old, 40-65 Years Old, Above 65 Years Old

What are the Type segmentation covered in the Rasagiline Tablet Market report?

Ans: The Types covered in the Rasagiline Tablet Market report are 0.5 mg/Pcs, 1 mg/Pcs

1 Rasagiline Tablet Market Overview

1.1 Product Definition

1.2 Rasagiline Tablet by Type

1.2.1 Global Rasagiline Tablet Market Value Comparison by Type (2024 VS 2031)

1.2.2 0.5 mg/Pcs

1.2.3 1 mg/Pcs

1.3 Rasagiline Tablet by Application

1.3.1 Global Rasagiline Tablet Market Value by Application (2024 VS 2031)

1.3.2 Under 40 Years Old

1.3.3 40-65 Years Old

1.3.4 Above 65 Years Old

1.4 Global Rasagiline Tablet Market Size Estimates and Forecasts

1.4.1 Global Rasagiline Tablet Revenue 2020-2031

1.4.2 Global Rasagiline Tablet Sales 2020-2031

1.4.3 Global Rasagiline Tablet Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Rasagiline Tablet Market Competition by Manufacturers

2.1 Global Rasagiline Tablet Sales Market Share by Manufacturers (2020-2025)

2.2 Global Rasagiline Tablet Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Rasagiline Tablet Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Rasagiline Tablet, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rasagiline Tablet, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rasagiline Tablet, Product Type & Application

2.7 Global Key Manufacturers of Rasagiline Tablet, Date of Enter into This Industry

2.8 Global Rasagiline Tablet Market Competitive Situation and Trends

2.8.1 Global Rasagiline Tablet Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Rasagiline Tablet Players Market Share by Revenue

2.8.3 Global Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Rasagiline Tablet Market Scenario by Region

3.1 Global Rasagiline Tablet Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Rasagiline Tablet Sales by Region: 2020-2031

3.2.1 Global Rasagiline Tablet Sales by Region: 2020-2025

3.2.2 Global Rasagiline Tablet Sales by Region: 2026-2031

3.3 Global Rasagiline Tablet Revenue by Region: 2020-2031

3.3.1 Global Rasagiline Tablet Revenue by Region: 2020-2025

3.3.2 Global Rasagiline Tablet Revenue by Region: 2026-2031

3.4 North America Rasagiline Tablet Market Facts & Figures by Country

3.4.1 North America Rasagiline Tablet Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Rasagiline Tablet Sales by Country (2020-2031)

3.4.3 North America Rasagiline Tablet Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Rasagiline Tablet Market Facts & Figures by Country

3.5.1 Europe Rasagiline Tablet Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Rasagiline Tablet Sales by Country (2020-2031)

3.5.3 Europe Rasagiline Tablet Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rasagiline Tablet Market Facts & Figures by Region

3.6.1 Asia Pacific Rasagiline Tablet Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Rasagiline Tablet Sales by Region (2020-2031)

3.6.3 Asia Pacific Rasagiline Tablet Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Rasagiline Tablet Market Facts & Figures by Country

3.7.1 Latin America Rasagiline Tablet Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Rasagiline Tablet Sales by Country (2020-2031)

3.7.3 Latin America Rasagiline Tablet Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rasagiline Tablet Market Facts & Figures by Country

3.8.1 Middle East and Africa Rasagiline Tablet Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Rasagiline Tablet Sales by Country (2020-2031)

3.8.3 Middle East and Africa Rasagiline Tablet Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rasagiline Tablet Sales by Type (2020-2031)

4.1.1 Global Rasagiline Tablet Sales by Type (2020-2025)

4.1.2 Global Rasagiline Tablet Sales by Type (2026-2031)

4.1.3 Global Rasagiline Tablet Sales Market Share by Type (2020-2031)

4.2 Global Rasagiline Tablet Revenue by Type (2020-2031)

4.2.1 Global Rasagiline Tablet Revenue by Type (2020-2025)

4.2.2 Global Rasagiline Tablet Revenue by Type (2026-2031)

4.2.3 Global Rasagiline Tablet Revenue Market Share by Type (2020-2031)

4.3 Global Rasagiline Tablet Price by Type (2020-2031)

5 Segment by Application

5.1 Global Rasagiline Tablet Sales by Application (2020-2031)

5.1.1 Global Rasagiline Tablet Sales by Application (2020-2025)

5.1.2 Global Rasagiline Tablet Sales by Application (2026-2031)

5.1.3 Global Rasagiline Tablet Sales Market Share by Application (2020-2031)

5.2 Global Rasagiline Tablet Revenue by Application (2020-2031)

5.2.1 Global Rasagiline Tablet Revenue by Application (2020-2025)

5.2.2 Global Rasagiline Tablet Revenue by Application (2026-2031)

5.2.3 Global Rasagiline Tablet Revenue Market Share by Application (2020-2031)

5.3 Global Rasagiline Tablet Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Teva Pharmaceutical

6.1.1 Teva Pharmaceutical Company Information

6.1.2 Teva Pharmaceutical Description and Business Overview

6.1.3 Teva Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Teva Pharmaceutical Rasagiline Tablet Product Portfolio

6.1.5 Teva Pharmaceutical Recent Developments/Updates

6.2 Lundbeck

6.2.1 Lundbeck Company Information

6.2.2 Lundbeck Description and Business Overview

6.2.3 Lundbeck Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Lundbeck Rasagiline Tablet Product Portfolio

6.2.5 Lundbeck Recent Developments/Updates

6.3 Sun Pharmaceutical

6.3.1 Sun Pharmaceutical Company Information

6.3.2 Sun Pharmaceutical Description and Business Overview

6.3.3 Sun Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sun Pharmaceutical Rasagiline Tablet Product Portfolio

6.3.5 Sun Pharmaceutical Recent Developments/Updates

6.4 Apotex

6.4.1 Apotex Company Information

6.4.2 Apotex Description and Business Overview

6.4.3 Apotex Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Apotex Rasagiline Tablet Product Portfolio

6.4.5 Apotex Recent Developments/Updates

6.5 Taj Pharma

6.5.1 Taj Pharma Company Information

6.5.2 Taj Pharma Description and Business Overview

6.5.3 Taj Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Taj Pharma Rasagiline Tablet Product Portfolio

6.5.5 Taj Pharma Recent Developments/Updates

6.6 Mylan

6.6.1 Mylan Company Information

6.6.2 Mylan Description and Business Overview

6.6.3 Mylan Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Mylan Rasagiline Tablet Product Portfolio

6.6.5 Mylan Recent Developments/Updates

6.7 Takeda Pharmaceutical

6.7.1 Takeda Pharmaceutical Company Information

6.7.2 Takeda Pharmaceutical Description and Business Overview

6.7.3 Takeda Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Takeda Pharmaceutical Rasagiline Tablet Product Portfolio

6.7.5 Takeda Pharmaceutical Recent Developments/Updates

6.8 Sandoz

6.8.1 Sandoz Company Information

6.8.2 Sandoz Description and Business Overview

6.8.3 Sandoz Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sandoz Rasagiline Tablet Product Portfolio

6.8.5 Sandoz Recent Developments/Updates

6.9 Intas Pharmaceuticals

6.9.1 Intas Pharmaceuticals Company Information

6.9.2 Intas Pharmaceuticals Description and Business Overview

6.9.3 Intas Pharmaceuticals Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Intas Pharmaceuticals Rasagiline Tablet Product Portfolio

6.9.5 Intas Pharmaceuticals Recent Developments/Updates

6.10 Natco Pharma

6.10.1 Natco Pharma Company Information

6.10.2 Natco Pharma Description and Business Overview

6.10.3 Natco Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Natco Pharma Rasagiline Tablet Product Portfolio

6.10.5 Natco Pharma Recent Developments/Updates

6.11 Ajanta Pharma

6.11.1 Ajanta Pharma Company Information

6.11.2 Ajanta Pharma Description and Business Overview

6.11.3 Ajanta Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Ajanta Pharma Rasagiline Tablet Product Portfolio

6.11.5 Ajanta Pharma Recent Developments/Updates

6.12 Orchid Pharma

6.12.1 Orchid Pharma Company Information

6.12.2 Orchid Pharma Description and Business Overview

6.12.3 Orchid Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Orchid Pharma Rasagiline Tablet Product Portfolio

6.12.5 Orchid Pharma Recent Developments/Updates

6.13 Alkem Laboratories

6.13.1 Alkem Laboratories Company Information

6.13.2 Alkem Laboratories Description and Business Overview

6.13.3 Alkem Laboratories Rasagiline Tablet Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Alkem Laboratories Rasagiline Tablet Product Portfolio

6.13.5 Alkem Laboratories Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rasagiline Tablet Industry Chain Analysis

7.2 Rasagiline Tablet Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rasagiline Tablet Production Mode & Process Analysis

7.4 Rasagiline Tablet Sales and Marketing

7.4.1 Rasagiline Tablet Sales Channels

7.4.2 Rasagiline Tablet Distributors

7.5 Rasagiline Tablet Customer Analysis

8 Rasagiline Tablet Market Dynamics

8.1 Rasagiline Tablet Industry Trends

8.2 Rasagiline Tablet Market Drivers

8.3 Rasagiline Tablet Market Challenges

8.4 Rasagiline Tablet Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

Sandoz Inc

Intas Pharmaceuticals

List of Tables

Table 1. Global Rasagiline Tablet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Rasagiline Tablet Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Rasagiline Tablet Market Competitive Situation by Manufacturers in 2024

Table 4. Global Rasagiline Tablet Sales (M Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Rasagiline Tablet Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Rasagiline Tablet Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Rasagiline Tablet Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Rasagiline Tablet Average Price (USD/K Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Rasagiline Tablet, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rasagiline Tablet, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rasagiline Tablet, Product Type & Application

Table 12. Global Key Manufacturers of Rasagiline Tablet, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rasagiline Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rasagiline Tablet as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rasagiline Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Rasagiline Tablet Sales by Region (2020-2025) & (M Pcs)

Table 18. Global Rasagiline Tablet Sales Market Share by Region (2020-2025)

Table 19. Global Rasagiline Tablet Sales by Region (2026-2031) & (M Pcs)

Table 20. Global Rasagiline Tablet Sales Market Share by Region (2026-2031)

Table 21. Global Rasagiline Tablet Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Rasagiline Tablet Revenue Market Share by Region (2020-2025)

Table 23. Global Rasagiline Tablet Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Rasagiline Tablet Revenue Market Share by Region (2026-2031)

Table 25. North America Rasagiline Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Rasagiline Tablet Sales by Country (2020-2025) & (M Pcs)

Table 27. North America Rasagiline Tablet Sales by Country (2026-2031) & (M Pcs)

Table 28. North America Rasagiline Tablet Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Rasagiline Tablet Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Rasagiline Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Rasagiline Tablet Sales by Country (2020-2025) & (M Pcs)

Table 32. Europe Rasagiline Tablet Sales by Country (2026-2031) & (M Pcs)

Table 33. Europe Rasagiline Tablet Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Rasagiline Tablet Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Rasagiline Tablet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Rasagiline Tablet Sales by Region (2020-2025) & (M Pcs)

Table 37. Asia Pacific Rasagiline Tablet Sales by Region (2026-2031) & (M Pcs)

Table 38. Asia Pacific Rasagiline Tablet Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Rasagiline Tablet Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Rasagiline Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Rasagiline Tablet Sales by Country (2020-2025) & (M Pcs)

Table 42. Latin America Rasagiline Tablet Sales by Country (2026-2031) & (M Pcs)

Table 43. Latin America Rasagiline Tablet Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Rasagiline Tablet Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Rasagiline Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Rasagiline Tablet Sales by Country (2020-2025) & (M Pcs)

Table 47. Middle East and Africa Rasagiline Tablet Sales by Country (2026-2031) & (M Pcs)

Table 48. Middle East and Africa Rasagiline Tablet Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Rasagiline Tablet Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Rasagiline Tablet Sales (M Pcs) by Type (2020-2025)

Table 51. Global Rasagiline Tablet Sales (M Pcs) by Type (2026-2031)

Table 52. Global Rasagiline Tablet Sales Market Share by Type (2020-2025)

Table 53. Global Rasagiline Tablet Sales Market Share by Type (2026-2031)

Table 54. Global Rasagiline Tablet Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Rasagiline Tablet Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Rasagiline Tablet Revenue Market Share by Type (2020-2025)

Table 57. Global Rasagiline Tablet Revenue Market Share by Type (2026-2031)

Table 58. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2020-2025)

Table 59. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2026-2031)

Table 60. Global Rasagiline Tablet Sales (M Pcs) by Application (2020-2025)

Table 61. Global Rasagiline Tablet Sales (M Pcs) by Application (2026-2031)

Table 62. Global Rasagiline Tablet Sales Market Share by Application (2020-2025)

Table 63. Global Rasagiline Tablet Sales Market Share by Application (2026-2031)

Table 64. Global Rasagiline Tablet Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Rasagiline Tablet Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Rasagiline Tablet Revenue Market Share by Application (2020-2025)

Table 67. Global Rasagiline Tablet Revenue Market Share by Application (2026-2031)

Table 68. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2020-2025)

Table 69. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2026-2031)

Table 70. Teva Pharmaceutical Company Information

Table 71. Teva Pharmaceutical Description and Business Overview

Table 72. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 73. Teva Pharmaceutical Rasagiline Tablet Product

Table 74. Teva Pharmaceutical Recent Developments/Updates

Table 75. Lundbeck Company Information

Table 76. Lundbeck Description and Business Overview

Table 77. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 78. Lundbeck Rasagiline Tablet Product

Table 79. Lundbeck Recent Developments/Updates

Table 80. Sun Pharmaceutical Company Information

Table 81. Sun Pharmaceutical Description and Business Overview

Table 82. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 83. Sun Pharmaceutical Rasagiline Tablet Product

Table 84. Sun Pharmaceutical Recent Developments/Updates

Table 85. Apotex Company Information

Table 86. Apotex Description and Business Overview

Table 87. Apotex Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 88. Apotex Rasagiline Tablet Product

Table 89. Apotex Recent Developments/Updates

Table 90. Taj Pharma Company Information

Table 91. Taj Pharma Description and Business Overview

Table 92. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 93. Taj Pharma Rasagiline Tablet Product

Table 94. Taj Pharma Recent Developments/Updates

Table 95. Mylan Company Information

Table 96. Mylan Description and Business Overview

Table 97. Mylan Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 98. Mylan Rasagiline Tablet Product

Table 99. Mylan Recent Developments/Updates

Table 100. Takeda Pharmaceutical Company Information

Table 101. Takeda Pharmaceutical Description and Business Overview

Table 102. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 103. Takeda Pharmaceutical Rasagiline Tablet Product

Table 104. Takeda Pharmaceutical Recent Developments/Updates

Table 105. Sandoz Company Information

Table 106. Sandoz Description and Business Overview

Table 107. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 108. Sandoz Rasagiline Tablet Product

Table 109. Sandoz Recent Developments/Updates

Table 110. Intas Pharmaceuticals Company Information

Table 111. Intas Pharmaceuticals Description and Business Overview

Table 112. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 113. Intas Pharmaceuticals Rasagiline Tablet Product

Table 114. Intas Pharmaceuticals Recent Developments/Updates

Table 115. Natco Pharma Company Information

Table 116. Natco Pharma Description and Business Overview

Table 117. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 118. Natco Pharma Rasagiline Tablet Product

Table 119. Natco Pharma Recent Developments/Updates

Table 120. Ajanta Pharma Company Information

Table 121. Ajanta Pharma Description and Business Overview

Table 122. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 123. Ajanta Pharma Rasagiline Tablet Product

Table 124. Ajanta Pharma Recent Developments/Updates

Table 125. Orchid Pharma Company Information

Table 126. Orchid Pharma Description and Business Overview

Table 127. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 128. Orchid Pharma Rasagiline Tablet Product

Table 129. Orchid Pharma Recent Developments/Updates

Table 130. Alkem Laboratories Company Information

Table 131. Alkem Laboratories Description and Business Overview

Table 132. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)

Table 133. Alkem Laboratories Rasagiline Tablet Product

Table 134. Alkem Laboratories Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Rasagiline Tablet Distributors List

Table 138. Rasagiline Tablet Customers List

Table 139. Rasagiline Tablet Market Trends

Table 140. Rasagiline Tablet Market Drivers

Table 141. Rasagiline Tablet Market Challenges

Table 142. Rasagiline Tablet Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Rasagiline Tablet

Figure 2. Global Rasagiline Tablet Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rasagiline Tablet Market Share by Type: 2024 & 2031

Figure 4. 0.5 mg/Pcs Product Picture

Figure 5. 1 mg/Pcs Product Picture

Figure 6. Global Rasagiline Tablet Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Rasagiline Tablet Market Share by Application: 2024 & 2031

Figure 8. Under 40 Years Old

Figure 9. 40-65 Years Old

Figure 10. Above 65 Years Old

Figure 11. Global Rasagiline Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Rasagiline Tablet Market Size (2020-2031) & (US$ Million)

Figure 13. Global Rasagiline Tablet Sales (2020-2031) & (M Pcs)

Figure 14. Global Rasagiline Tablet Average Price (USD/K Pcs) & (2020-2031)

Figure 15. Rasagiline Tablet Report Years Considered

Figure 16. Rasagiline Tablet Sales Share by Manufacturers in 2024

Figure 17. Global Rasagiline Tablet Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Rasagiline Tablet Players: Market Share by Revenue in Rasagiline Tablet in 2024

Figure 19. Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Rasagiline Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Rasagiline Tablet Sales Market Share by Country (2020-2031)

Figure 22. North America Rasagiline Tablet Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Rasagiline Tablet Sales Market Share by Country (2020-2031)

Figure 26. Europe Rasagiline Tablet Revenue Market Share by Country (2020-2031)

Figure 27. Germany Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Rasagiline Tablet Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Rasagiline Tablet Revenue Market Share by Region (2020-2031)

Figure 34. China Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Rasagiline Tablet Sales Market Share by Country (2020-2031)

Figure 44. Latin America Rasagiline Tablet Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Rasagiline Tablet Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Rasagiline Tablet Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Rasagiline Tablet Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Rasagiline Tablet by Type (2020-2031)

Figure 54. Global Revenue Market Share of Rasagiline Tablet by Type (2020-2031)

Figure 55. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2020-2031)

Figure 56. Global Sales Market Share of Rasagiline Tablet by Application (2020-2031)

Figure 57. Global Revenue Market Share of Rasagiline Tablet by Application (2020-2031)

Figure 58. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2020-2031)

Figure 59. Rasagiline Tablet Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions